[Federal Register Volume 87, Number 92 (Thursday, May 12, 2022)]
[Notices]
[Pages 29160-29161]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-10142]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Solicitation of Nominations for Appointment to CDC's Advisory 
Committee to the Director (ACD) Laboratory Workgroup (LW); Amended 
Notice

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Amended notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) gives 
notice of a change in the solicitation of CDC's Advisory Committee to 
the Director (ACD) Laboratory Workgroup (LW), in the original FRN 
published on May 4, 2022. The request for nominations is being amended 
to update the language in the supplementary information section of the 
notice, restated below.

DATES: Nominations for membership on the LW workgroup must be received 
no later than May 16, 2022. Late nominations will not be considered for 
membership.

ADDRESSES: All nominations (cover letters and curriculum vitae) should 
be emailed to [email protected] with the subject line: ``Nomination for CDC 
ACD LW Workgroup.''

FOR FURTHER INFORMATION CONTACT: Lauren Hoffmann, MA, Office of the 
Chief of Staff, Centers for Disease Control and Prevention, 1600 
Clifton Road NE, Mailstop H21-10, Atlanta, Georgia 30329-4027; 
Telephone: (404) 639-7000; Email: [email protected].

SUPPLEMENTARY INFORMATION:
    Background: The purpose of the ACD, CDC is to advise the Secretary, 
HHS, and the Director, CDC, on policy and broad strategies that will 
enable CDC to fulfill its mission of protecting health through health 
promotion, prevention, and preparedness. The ACD, CDC consists of up to 
15 non-federal members, including the Chair, knowledgeable in areas 
pertinent to the CDC mission, such as health policy, public health, 
global health, preparedness, preventive medicine, the faith-based and 
community-based sector, and allied fields. The request for nominations 
in the original published FRN was published in the Federal Register on 
May 4, 2022, Volume 87, Number 86, page 26358.
    Purpose: The establishment and formation of the LW is to provide 
input to the ACD, CDC on agency-wide activities related to laboratory 
quality management, continuous laboratory quality improvement, and 
laboratory diagnostic testing to support public health programs and 
investigations. The LW membership will consist of up to 15 members. It 
will be co-chaired by two current ACD, CDC Special Government 
Employees. The LW co-chairs will present their findings, observations, 
and work products at one or more ACD, CDC meetings for discussion, 
deliberation, and decisions (final recommendations to CDC).
    Nomination Criteria: LW members will serve terms ranging from six 
months to one year and be required to attend LW meetings approximately 
1-2 times per month (virtually or in person), and contribute time 
between meetings for research, consultation, discussion, and writing 
assignments.
    Nominations are being sought for individuals who have the expertise 
and qualifications necessary to contribute to the accomplishments of 
the committee's/workgroup's objectives. Nominees will be selected based 
on expertise in the fields of public health laboratory science and 
practice, laboratory quality management, diagnostic regulations, and 
clinical laboratory testing and research. To ensure a diverse workgroup 
composition, nominees with front line and field experience at the 
local, state, tribal, and territorial levels are encouraged to apply. 
Federal employees will not be considered for membership. Selection of 
members is based on candidates' qualifications to contribute to the 
accomplishment of the LW's objectives.
    HHS policy stipulates that membership be balanced in terms of 
points of view represented and the workgroup's function. Appointments 
shall be made without discrimination based on age, race, ethnicity, 
gender, sexual orientation, gender identity, HIV status, disability, 
and cultural, religious, or socioeconomic status. Nominees cannot be 
full-time employees of the U.S. Government. Current participation on 
federal workgroups or prior experience serving on a federal advisory 
committee does not disqualify a candidate; however, HHS policy is to 
avoid excessive individual service on advisory committees and multiple 
committee memberships. Interested candidates should submit the 
following items:
    [ssquf] A one-half to one-page cover letter that includes your 
understanding of, and commitment to, the time and work necessary; one 
to two sentences on your background and experience; and one to two 
sentences on the skills/perspective you would bring to the LW.
    [ssquf] Current curriculum vitae which highlights the experience 
and work history being sought relevant to the criteria set forth above, 
including complete contact information (telephone numbers, mailing 
address, email address).
    Nominations may be submitted by the candidate him or herself, or by 
the person/organization recommending the candidate no later than May 
16, 2022. All nominations (cover letters and curriculum vitae) should 
be emailed to [email protected] with the subject line: ``Nomination for CDC 
ACD LW Workgroup.''

[[Page 29161]]

    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-10142 Filed 5-11-22; 8:45 am]
BILLING CODE 4163-18-P